Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells

International Journal of Cancer

Volumn 82, Issue 2, 1999, Pages 268-273

  Reddy, Kaladhar B ^a   Krueger, Joseph S ^a   Kondapaka, Sudhir B ^a   Diglio, Clement A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST; BREAST NEOPLASMS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELLS, CULTURED; ENZYME INDUCTION; ENZYME INHIBITORS; ENZYME PRECURSORS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GELATINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE KINASE 1; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033050405     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.0.CO;2-4     Document Type: Article

References (26)

1. ANGEL, P., BAUMANN, I., STEIN, B., DELIUS, H., RAHMSDORF, H.J. and HERRLICH, P., 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. cell. Biol., 7, 2256-2266 (1987).
2. BRUNET, A., PAGES, G. and POUYSSEGUR, J., Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene, 9, 3379-3387 (1994).
3. CHOUDHURY, G.G., WANG, L.M., PIERCE, J., HARVEY, S.A. and SAKAGUCHI, A.Y., A mutational analysis of phosphatidylinositol-3-kinase activation by human colony-stimulating factor-1 receptor. J. biol. Chem., 266, 8068-8072 (1991).
4. COBB, M.H. and GOLDSMITH, E.J., How MAP kinases are regulated. J. biol. Chem., 270, 14843-14846 (1995).
5. DAVIS, R.J., The mitogen-activated protein kinase signal transduction pathway. J. biol. Chem., 268, 14553-14556 (1993).
6. EMMERT-BUCK, M.R., EMONARD, H.P., CORCORAN, M.L., KRUTZSCH, H.C., FOIDART, J.M. and STETLER-STEVENSON, W.G., Cell surface binding of TIMP-2 and pro-MMP-2/TIMP-2 complex. FEBS Lett., 364, 28-32 (1995).
7. GOLDBERG, G.I., MARMER, B.L., GRANT, G.A., EISEN, A.Z., WILHELM, S. and HE, C.S., Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc. nat. Acad. Sci. (Wash.), 86, 8207-8211 (1989).
8. GOMEZ, N. and COHEN, P., Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature (Lond.), 353, 170-173 (1991).
9. INGBER, D.E. and FOLKMAN, J., How does extracellular matrix control capillary morphogenesis? Cell, 58, 803-805 (1989).
10. ITO, A., NAKAJIMA, S., SASAGURI, Y., NAGASE, H. and MORI, Y., Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Brit. J. Cancer, 71, 1039-1045 (1995).
11. KONDAPAKA, S.B., FRIDMAN, R. and REDDY, K.B., Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int. J. Cancer, 70, 722-726 (1997).
12. KUO, M.L. and YANG, N.C., Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem. biophys. Res. Comm., 212, 767-775 (1995).
13. LIOTTA, L.A., STEEG, P.S. and STETLER-STEVENSON, W.G., Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336 (1991).
14. MANSOUR, S.J., MATTEN, W.T., HERMANN, A.S., CANDIA, J.M., RONG, S., FUKASAWA, K., VANDE WOUDE, G.F. and AHN, N.G., Transformation of mammalian cells by constitutively active MAP kinase kinase. Science, 265, 966-970 (1994).
15. MIGNATTI, P. and RIFKIN, D.B., Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein, 49, 117-137 (1996).
16. MONTEAGUDO, C., MERINO, M.J., SAN-JUAN, J., LIOTTA, L.A. and STETLER-STEVENSON, W.G., Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Amer. J. Pathol, 136, 585-592 (1990).
17. OKA, H., CHATANI, Y., HOSHINO, R., OGAWA, O., KAKEHI, Y., TERACHI, T., OKADA, Y., KAWAICHI, M., KOHNO, M. and YOSHIDA, O., Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res., 55, 4182-4187 (1995).
18. POLETTE, M., CLAVEL, C., COCKETT, M., GIROD DE BENTZMANN, S., MURPHY, G. and BIREMBAUT, P., Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis, 13, 31-37 (1993).
19. REE, A.H., BJORNLAND, K., BRUNNER, N., JOHANSEN, H.T., PEDERSEN, K.B., AASEN, A.O. and FODSTAD, O., Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells. Clin. exp. Metastasis, 16, 205-215 (1998).
20. ROBINSON, C.J., SCOTT, P.H., ALLAN, A.B., JESS, T., GOULD, G.W. and PLEVIN, R., Treatment of vascular smooth muscle cells with antisense phosphorothioate oligodeoxynucleotides directed against p42 and p44 mitogen-activated protein kinases abolishes DNA synthesis in response to platelet-derived growth factor. Biochem. J., 320, 123-127 (1996).
21. SAIKI, I., FUJII, H., YONEDA, J., ABE, F., NAKAJIMA, M., TSURUO, T. and AZUMA, I., Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer, 54, 137-143 (1993).
22. SATO, H., KITA, M. and SEIKI, M., v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements: a mechanism regulating gene expression independent of that by inflammatory cytokines. J. biol Chem., 268, 23460-23468 (1993).
23. SATO, H., TAKINO, T., OKADA, Y., CAO, J., SHINAGAWA, A., YAMAMOTO, E. and SEIKI, M., A matrix metalloproteinase expressed on the surface of invasive tumour cells [see comments]. Nature (Lond.), 370, 61-65 (1994).
24. SIVARAMAN, V.S., WANG, H., NUOVO, G.J. and MALBON, C.C., Hyperexpression of mitogen-activated protein kinase in human breast cancer [see comments]. J. clin. Invest., 99, 1478-1483 (1997).
25. STETLER-STEVENSON, W.G., Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev., 9, 289-303 (1990).
26. VISSCHER, D.W., SARKAR, F.H., KASUNIC, T.C. and REDDY, K.B., Clinico-pathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia. Breast Cancer Res. Treat., 45, 75-80 (1997).